Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Shares Outstanding (2016 - 2025)

Anaptysbio (ANAB) has disclosed Shares Outstanding for 8 consecutive years, with $26.6 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Shares Outstanding fell 6.27% year-over-year to $26.6 million, compared with a TTM value of $26.6 million through Sep 2023, down 6.27%, and an annual FY2022 reading of $28.5 million, up 3.13% over the prior year.
  • Shares Outstanding was $26.6 million for Q3 2023 at Anaptysbio, roughly flat from $26.5 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $28.5 million in Q4 2022 and bottomed at $26.5 million in Q2 2023.
  • Average Shares Outstanding over 5 years is $27.4 million, with a median of $27.3 million recorded in 2020.
  • The sharpest move saw Shares Outstanding grew 13.39% in 2019, then decreased 6.27% in 2023.
  • Year by year, Shares Outstanding stood at $27.3 million in 2019, then increased by 0.37% to $27.4 million in 2020, then rose by 1.06% to $27.6 million in 2021, then rose by 3.13% to $28.5 million in 2022, then fell by 6.8% to $26.6 million in 2023.
  • Business Quant data shows Shares Outstanding for ANAB at $26.6 million in Q3 2023, $26.5 million in Q2 2023, and $27.0 million in Q1 2023.